丘脑病变的显微外科切除:单术者大样本连续病例的手术结果与考量
该回顾性单中心连续病例研究纳入2007年2月至2019年8月接受经池或经胼胝体-经脑室内镜辅助显微手术的92例丘脑病变患者,平均切除程度95%(中位100%),无手术死亡,59.8%患者KPS改善,8.7%出现新发永久性神经功能缺损,7.6%需脑脊液分流。
要点
- 内镜辅助显微手术可切除丘脑病变,致残率可接受
- 应通过四个可及丘脑表面之一入路,避免损伤正常脑实质
- 高级别胶质瘤患者术后易出现脑脊液循环障碍,宜优先AIT入路
核心结论
- 内镜辅助显微手术可切除丘脑病变,致残率可接受;术者应通过四个可及丘脑表面之一入路,避免或最小化正常脑实质损伤。
- 高级别胶质瘤患者术后易出现脑脊液循环障碍,宜优先选择AIT入路以利于显微第三脑室造瘘和术中MRI。
研究设计与样本
- 回顾性单中心连续病例研究,2007年2月至2019年8月纳入92例丘脑病变患者,所有手术及患者数据前瞻性收集。
- 根据病变与可及丘脑表面关系选择TCi或TCTV入路,包括AIT、PITS、PeST、PeCSS;2018年1月起术中MRI纳入方案。
主要发现
- 92例中81例胶质瘤、6例海绵状血管畸形、2例生殖细胞瘤、1例转移瘤、1例动静脉畸形、1例室管膜囊肿;无经皮质入路。
- AIT 35例、PITS 35例、PeST 19例、PeCSS 3例;平均随访38个月(中位20个月,范围1-137个月),无失访。
- 平均切除程度95%(中位100%,范围21%-100%),无手术死亡;59.8%患者KPS改善,8例(8.7%)出现新发永久性神经功能缺损。
- 7例(7.6%)术后早期(<3个月)出现需分流的脑脊液循环问题,其中6/7例为高级别胶质瘤患者。
临床怎么用
- 丘脑病变手术应依据病变与侧脑室、膜帆、脑池、第三脑室等可及表面的关系选择TCi或TCTV入路。
- 高级别胶质瘤患者术后需警惕脑脊液循环障碍,可优先考虑AIT入路以便行显微第三脑室造瘘和术中MRI。
局限性
- 回顾性单术者连续病例研究,结果可能受术者经验和选择偏倚影响;术中MRI仅自2018年1月起纳入方案。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The object of this study was to present the surgical results of a large, single-surgeon consecutive series of patients who had undergone transcisternal (TCi) or transcallosal-transventricular (TCTV) endoscope-assisted microsurgery for thalamic lesions. METHODS: This is a retrospective study of a consecutive series of patients harboring thalamic lesions and undergoing surgery at one institution between February 2007 and August 2019. All surgical and patient-related data were prospectively collected. Depending on the relationship between the lesion and the surgically accessible thalamic surfaces (lateral ventricle, velar, cisternal, and third ventricle), one of the following surgical TCi or TCTV approaches was chosen: anterior interhemispheric transcallosal (AIT), posterior interhemispheric transtentorial subsplenial (PITS), perimedian supracerebellar transtentorial (PeST), or perimedian contralateral supracerebellar suprapineal (PeCSS). Since January 2018, intraoperative MRI has also been part of the protocol. The main study outcome was extent of resection. Complete neurological examination took place preoperatively, at discharge, and 3 months postoperatively. Descriptive statistics were calculated for the whole cohort. RESULTS: In the study period, 92 patients underwent surgery for a thalamic lesion: 81 gliomas, 6 cavernous malformations, 2 germinomas, 1 metastasis, 1 arteriovenous malformation, and 1 ependymal cyst. In none of the cases was a transcortical approach adopted. Thirty-five patients underwent an AIT approach, 35 a PITS, 19 a PeST, and 3 a PeCSS. The mean follow-up was 38 months (median 20 months, range 1-137 months). No patient was lost to follow-up. The mean extent of resection was 95% (median 100%, range 21%-100%), and there was no surgical mortality. Most patients (59.8%) experienced improvement in their Karnofsky Performance Status. New permanent neurological deficits occurred in 8 patients (8.7%). Early postoperative (< 3 months after surgery) problems in CSF circulation requiring diversion occurred in 7 patients (7.6%; 6/7 cases in patients with high-grade glioma). CONCLUSIONS: Endoscope-assisted microsurgery allows for the removal of thalamic lesions with acceptable morbidity. Surgeons must strive to access any given thalamic lesion through one of the four accessible thalamic surfaces, as they can be reached through either a TCTV or TCi approach with no or minimal damage to normal brain parenchyma. Patients harboring a high-grade glioma are likely to develop a postoperative disturbance of CSF circulation. For this reason, the AIT approach should be favored, as it facilitates a microsurgical third ventriculocisternostomy and allows intraoperative MRI to be done.
引用
- Serra C, Türe H, Yaltırık CK, et al. Microneurosurgical removal of thalamic lesions: surgical results and considerations from a large, single-surgeon consecutive series. J Neurosurg. 2020. PMID: 33007756. doi:10.3171/2020.6.JNS20524
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。